Welcome to The Pharmacogenomics Journal
The Pharmacogenomics Journal is dedicated to the rapid
publication of original research on basic pharmacogenomics research and its
clinical applications. Publishing six times a year, the journal aims to provide
the highest caliber of coverage concerning the effects of genetic variablity on
drug toxicity and efficacy, the characterization of polymorphisms relevant to
drug action, and the identification of novel genomic targets for drug development.
Looking for more information on pharmacogenomics? Read about its scope, limitations and applications in this article, featuring The Pharmacogenomics Journal's own Julio Licinio.
NEW FROM NATURE PUBLISHING GROUP: Translational Psychiatry
Editor-in-Chief: Julio Licinio, MD
Translational Psychiatry, a sister journal to Molecular Psychiatry, is a new online-only, open access publication that provides high quality research, a respected editorial team, rapid publication and high visibility. Submit your research today! Visit www.nature.com/tp/.
*** Announcing Open Access publication option ***
The Pharmacogenomics Journal now offers authors the option to publish their articles with immediate open access upon publication. Open access articles will also be deposited on PubMed Central at the time of publication and will be freely available immediately. Find out more from the press release or our FAQs page.
Volume 11, No 4
August 2011
ISSN: 1470-269X
EISSN: 1473-1150
Impact Factor 4.306*
Editor:
Julio Licinio, MD
*2010 Journal Citation Report (Thomson Reuters, 2011)
FEATURED ARTICLES
PERSPECTIVE
Genetic testing for ALDH2 deficiency FREEORIGINAL ARTICLE
Association of DISC1 missense variants with URS FREEORIGINAL ARTICLE
GST and cancer in the general population FREEORIGINAL ARTICLE
CYP3A5*3 and diltiazem-tacrolimus interaction FREETOP 5 MOST VIEWED PAPERS IN JUNE 2011
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity [415 views]
Informed consent in the context of pharmacogenomic research: ethical considerations [378 views]
Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy [325 views]
High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome [201 views]
Gene expression in blood is associated with risperidone response in children with autism spectrum disorders [172 views]
NEWS
Visit the MAQC II Web Focus: this collaboration between The Pharmacogenomics Journal and Nature Biotechnology brings you the results of the second phase of the MicroArray Quality Control project, an effort to create a series of best practices for replicating data from genotyping microarrays.
Want to order a poster of a Pharmacogenomics Journal cover? If so, follow this link to the order form.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
- Virally delivered Channelrhodopsin-2 Safely and Effectively Restores Visual Function in Multiple Mouse Models of Blindness - this content is FREE Source: Molecular Therapy
- The future of model organisms in human disease research Source: Nature Reviews Genetics
- An integrated semiconductor device enabling non-optical genome sequencing Source: Nature